These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Nevada
|
26-0287664
|
|
|
(State or other jurisdiction of
|
(I.R.S. Employer
|
|
|
incorporation or organization)
|
Identification No.)
|
|
Large Accelerated Filer
¨
|
Accelerated Filer
¨
|
|
Non-accelerated Filer
¨
(Do not check if a smaller reporting company)
|
Smaller Reporting Company
x
|
|
Page
|
||
|
PART I
|
||
|
Item 1.
|
Business
|
1
|
|
Item 1A
|
Rick Factors
|
6
|
|
Item 1B
|
Unresolved Staff Comments
|
9
|
|
Item 2.
|
Properties
|
10
|
|
Item 3.
|
Legal Proceedings
|
10
|
|
Item 4.
|
[Reserved]
|
10
|
|
PART II
|
||
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchase of Equity Securities
|
10
|
|
Item 6
|
Selected Financial Data
|
11
|
|
Item 7.
|
Management's Discussion and Analysis of Financial Condition and Results of Operation
|
11
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
12
|
|
Item 9.
|
Changes In and Disagreements with Accountants on Accounting and Financial Disclosure
|
12
|
|
Item 9A(T).
|
Controls and Procedures
|
12
|
|
Item 9B.
|
Other Information
|
13 |
|
PART III
|
||
|
Item 10.
|
Directors, Executive Officers, Promoters and Corporate Governance
|
14
|
|
Item 11.
|
Executive Compensation
|
15
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management
|
|
|
and Related Stockholder Matters
|
17
|
|
|
Item 13.
|
Certain Relationship and Related Transactions, and Director Independence
|
17
|
|
Item 14.
|
Principal Accountant Fees and Services
|
18
|
|
Item 15.
|
Exhibits
|
18
|
|
SIGNATURES
|
19
|
|
|
|
·
|
business strategy;
|
|
|
·
|
financial strategy;
|
|
|
·
|
intellectual property;
|
|
|
·
|
production;
|
|
|
·
|
future operating results; and
|
|
|
·
|
plans, objectives, expectations and intentions contained in this report that are not historical.
|
|
|
·
|
Limited Capital Requirements
|
|
|
·
|
Clean balance sheet and minimal leverage requirements
|
|
|
·
|
No capital cost for manufacturing, no time wasted on building distribution
|
|
|
·
|
Collaborate with major players instead of competing with them
|
|
|
·
|
Diversified revenue streams (large customer sales now, blending into licensing annuities)
|
|
1.
|
On July 28, 2007, to protect the intellectual property rights for “Algae Growth System for Oil Production”. The inventors listed on the patent application are Nicholas Eckelberry and T. Riggs Eckelberry, the Company’s founders. The Company is listed as the assignee. We have received initial correspondence from the USPTO, with respect to this patent application.
|
|
2.
|
On May 23, 2008, to protect the intellectual property rights for “Apparatus And Method For Optimizing Photosynthetic Growth In a Photo Bioreactor”. The inventors listed on the patent application are Steven Shigematsu and Nicholas Eckelberry. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
3.
|
On May 30, 2008, to protect the intellectual property rights for “Modular Portable Photobioreactor System”. The inventors listed on the patent application are Steven Shigematsu and Nicholas Eckelberry. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
4.
|
On January 6, 2009, to protect the intellectual property rights for “Apparatus And Method For Optimizing Photosynthetic Growth In A Photobioreactor”. The inventor listed on the patent application is Nicholas Eckelberry. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
5.
|
On April 17, 2009, to protect the intellectual property rights for “Device and Method for Separation, Cell Lysing and Flocculation of Algae From Water”. The inventor listed on the patent application is Nicholas Eckelberry. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
6.
|
On July 13, 2009, a provisional filing to protect the intellectual property rights for “Algae Growth Lighting and Control System”. The inventors listed on the patent application are Scott Fraser, Vikram Pattarkine, Ralph Anderson and Nicholas Eckelberry. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
7.
|
On July 26, 2009, a provisional filing to protect the intellectual property rights for “Procedure For Extraction Of Lipids From Algae Without Cell Sacrifice”. The inventors listed on the patent application are Paul Reep and Scott Fraser. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
8.
|
On September 30, 2009, a provisional filing to protect the intellectual property rights for “Methods and Apparatus for Growing Algae on a Solid Surface”. The inventors listed on the patent application are and Scott Fraser and Vikram Pattarkine. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
9.
|
On June 18, 2010, a provisional filing to protect the intellectual property rights for “Bio-Energy Reactor”. The inventors listed on the patent application is Michael Green. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
10.
|
On October 17, 2010, a provisional filing to protect the intellectual property rights for “Methods and Apparatus for Dewatering, Flocculation and Harvesting of Algae Cells”. The inventors listed on the patent application are Michael Green, Nicholas Eckelberry, Scott Fraser and Brian Goodall. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
11.
|
On October 20, 2010, a provisional filing to protect the intellectual property rights for “Methods and Apparatus for Dewatering, Flocculation and Harvesting of Algae Cells”. The inventors listed on the patent application are Michael Green, Nicholas Eckelberry, Scott Fraser and Brian Goodall. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
12.
|
On March 18, 2011, a provisional filing to protect the intellectual property rights for “Enhancing Algae Growth by Reducing Competing Microorganisms in a Growth Medium”. The inventors listed on the patent application are Michael Green, Scott Fraser, Nicholas Eckelberry and Jose Sanchez. The Company is listed as the assignee. We have not received any correspondence from the USPTO, with respect to this patent application.
|
|
|
·
|
Successfully execute its business strategy;
|
|
|
·
|
Respond to competitive developments; and
|
|
|
·
|
Attract, integrate, retain and motivate qualified personnel.
|
|
|
·
|
There can be no assurance that at this time we will operate profitably or that we will have adequate working capital to meet our obligations as they become due. Subscribers must consider the risks and difficulties frequently encountered by early stage companies, particularly in rapidly evolving markets.
|
|
|
·
|
price and volume fluctuations in the overall stock market from time to time;
|
|
|
·
|
significant volatility in the market price and trading volume of securities of companies in our industry; and
|
|
|
·
|
general economic conditions and trends.
|
|
|
·
|
A penny stock is generally a stock that:
|
|
|
·
|
is not listed on a national securities exchange or NASDAQ,
|
|
|
·
|
is listed in the "pink sheets" or on the NASD OTC Bulletin Board,
|
|
|
·
|
has a price per share of less than $5.00 and
|
|
|
·
|
is issued by a company with net tangible assets less than $5 million.
|
|
|
·
|
determination of the purchaser's investment suitability,
|
|
|
·
|
delivery of certain information and disclosures to the purchaser, and
|
|
|
·
|
receipt of a specific purchase agreement before effecting the purchase transaction.
|
|
|
·
|
such rules may materially limit or restrict the ability to resell our Common Stock, and
|
|
|
·
|
the liquidity typically associated with other publicly traded equity securities may not exist.
|
|
Year
|
Fiscal Quarter Period
|
High
|
Low
|
|||||||
|
2009
|
January 1, 2009 to March 31, 2009
|
0.45
|
0. 32
|
|||||||
|
April 1, 2009 to June 30, 2009
|
0.48
|
0. 27
|
||||||||
|
July 1, 2009 to September 30, 2009
|
0.40
|
0. 22
|
||||||||
|
October 1, 2009 to December 31, 2009
|
0.39
|
0. 25
|
||||||||
|
2010
|
January 1, 2010 to March 31, 2010
|
0.35
|
0. 25
|
|||||||
|
April 1, 2010 to June 30, 2010
|
0.34
|
0. 20
|
||||||||
|
July 1, 2010 to September 30, 2010
|
0.25
|
0. 14
|
||||||||
|
October 1, 2010 to December 31, 2010
|
0.22
|
0. 11
|
||||||||
|
Name
|
Age
|
Position
|
||
|
T. Riggs Eckelberry
|
59
|
Chief Executive Officer and Chairman of the Board of Directors, Secretary, Treasurer, President and acting Chief Financial Officer.
|
||
|
Ivan Ivankovich
|
43
|
Director
|
||
|
Paul Reep
|
62
|
Director
|
|
Principal
Position
|
Year
|
Salary
($)
|
Bonus
($)s
|
Option
Awards
|
Non-Equity
Incentive Plan
Compensation
|
Change in
Pension Value
and Non-
Qualified
Deferred
Compensation
Earnings ()
|
All other
Compensation
|
Total ($)
|
||||||||||||||||||||||
|
T. Riggs Eckelberry
Chief Executive Officer
|
||||||||||||||||||||||||||||||
|
2008
|
260,000 | 0 | 0 | 0 | 0 | 0 | 260,000 | |||||||||||||||||||||||
|
2009
|
260,000 | 110,000 | 0 | 0 | 0 | 0 | 370,000 | |||||||||||||||||||||||
|
2010
|
260,000 | 100,000 | 0 | 0 | 0 | 0 | 360,000 | |||||||||||||||||||||||
|
Equity Compensation Plan Information
|
||||||||||||
|
Plan category
|
Number of securities to be
issued upon exercise of
outstanding options
(a)
|
Weighted-average
exercise price of
outstanding options
(b)
|
Securities remaining available
for future issuance under equity
compensation plans (excluding
securities reflected in column (a))
(c)
|
|||||||||
|
Equity compensation plans approved by security holders
|
14,948,750 | 0.24 | 51,250 | |||||||||
|
Equity compensation plans not approved by security holders
|
- | - | ||||||||||
|
Total
|
14,948,750 | 0.24 | 51,250 | |||||||||
|
Weighted
|
|||||||||||||||
|
Average
|
|||||||||||||||
|
Remaining
|
|||||||||||||||
|
Exercisable
|
Warrants
|
Warrants
|
Contractual
|
||||||||||||
|
Prices
|
Outstanding
|
Exercisable
|
Life (years)
|
||||||||||||
| $ | 0.31 | 9,700,000 | 9,700,000 | 3.50 | |||||||||||
| $ | 0.34 | 1,100,000 | 900,000 | 3.63 | |||||||||||
| $ | 0.30 | 525,000 | 525,000 | 3.81 | |||||||||||
| $ | 0.28 | 250,000 | 250,000 | 3.87 | |||||||||||
| $ | 0.28 | 20,000 | 20,000 | 4.08 | |||||||||||
| $ | 0.28 | 150,000 | 150,000 | 4.41 | |||||||||||
| $ | 0.24 | 1,000,000 | 1,000,000 | 4.48 | |||||||||||
| $ | 0.31 | 220,000 | 220,000 | 4.59 | |||||||||||
| $ | 0.15 | 350,000 | 350,000 | 4.70 | |||||||||||
| $ | 0.24 | 250,000 | 250,000 | 4.73 | |||||||||||
| $ | 0.24 | 1,000,000 | 1,000,000 | 4.75 | |||||||||||
| $ | 0.12 | 250,000 | 250,000 | 4.83 | |||||||||||
| $ | 0.15 | 1,000,000 | 1,000,000 | 4.90 | |||||||||||
| $ | 0.14 | 400,000 | 400,000 | 4.92 | |||||||||||
| $ | 0.20 | 5,000,000 | 5,000,000 | 4.98 | |||||||||||
| $ | 0.20 | 1,000,000 | 1,000,000 | 4.99 | |||||||||||
| 22,215,000 | 22,015,000 | ||||||||||||||
|
Name
(a)
|
Fees Earned or Paid
in Cash
($) (b)
|
Stock
Awards
($) (c)
|
Option
Awards
($) (d)
|
Non-Equity
Incentive Plan
Compensation
($) (e)
|
All Other
Compensation
($) (g)
|
Total
($) (h)
|
||||||||||||||||||
|
Ivan Ivankovich
|
- | - | 220,000 | - | - | 220,000 | ||||||||||||||||||
|
Adam Meislik
|
- | - | 220,000 | - | - | 220,000 | ||||||||||||||||||
|
Name and Title of Beneficial Owner
|
|
Number of Shares
Beneficially Owned (1)
|
|
|
Percentage of Shares
|
|
||
|
T. Riggs Eckelberry,
Chief Executive Officer, and Director
|
39,735,000
|
19.8
|
%
|
|||||
|
Ivan Ivankovich, Director (2)
|
3,500,000
|
1.7
|
%
|
|||||
|
Paul Reep, Director (3)
|
1,000,000 |
0.5
|
%
|
|||||
|
Directors and executive officers as a group (3 persons)
|
44,235,000
|
21.6
|
%
|
|||||
|
(1)
|
Unless otherwise indicated and subject to applicable community property laws, to our knowledge each stockholder named in the table possesses sole voting and investment power with respect to all shares of Common Stock, except for those owned jointly with that person’s spouse.
|
|
(2)
|
Includes 500,000 Shares of Common Stock, a warrant to purchase 1,000,000 Shares of the Company’s common stock at a price of $0.31 per Share, and a warrant to purchase 2,000,000 Shares of the Company’s common stock at a price of $0.20 per Share.
|
|
(3)
|
Includes 250,000 Shares of Common Stock, a warrant to purchase 750,000 Shares of the Company’s common stock at a price of $0.31 per Share.
|
|
SEC Ref. No.
|
|||
|
3.1
|
Articles of Incorporation
|
||
|
3.3
|
By-laws
|
||
|
10.4
|
OriginOil, Inc. 2009 Incentive Stock Plan (2)
|
||
| 14 | Code of Ethics (2) | ||
|
31
|
Certification of Chief Executive Officer pursuant to Sec. 302 of the Sarbanes-Oxley Act of 2002 (2)
|
||
|
32
|
Certification of Chief Executive Officer pursuant to 18 U.S.C. SECTION 1350 (2)
|
|
(1)
|
Incorporated by reference to the Company’s SB-2 filed with the Securities and Exchange Commission on December 11, 2007.
|
|
(2)
|
Filed herewith
|
|
ORIGINOIL, INC.
|
|||
|
By:
|
/s/ T Riggs Eckelberry
|
||
|
T Riggs Eckelberry
|
|||
|
Chief Executive Officer (Principal Executive Officer)
|
|||
|
and Acting Chief Financial Officer
|
|||
|
(Principal Accounting and Financial Officer)
|
|||
|
Date: March 30, 2011
|
By:
|
/s/ T Riggs Eckelberry
|
|
|
T Riggs Eckelberry
|
|||
|
Director
|
|
Date: March 30, 2011
|
By:
|
/s/ Paul Reep
|
|
|
Paul Reep
|
|||
|
Director
|
|
Date: March 30, 2011
|
By:
|
/s/ Ivan Ivankovich
|
|
|
Ivan Ivankovich
|
|||
|
Director
|
|
December 31,
2010
|
December 31,
2009
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
Cash & cash equivalents
|
$ | 238,424 | $ | 356,179 | ||||
|
Prepaid expenses
|
86,996 | 32,867 | ||||||
|
Other receivables
|
14,018 | - | ||||||
|
TOTAL CURRENT ASSETS
|
339,438 | 389,046 | ||||||
|
PROPERTY & EQUIPMENT
|
||||||||
|
Machinery & equipment
|
1,372 | 1,372 | ||||||
|
Furniture & fixtures
|
27,056 | 27,056 | ||||||
|
Computer equipment
|
26,304 | 22,268 | ||||||
|
Leasehold improvements
|
94,914 | 94,914 | ||||||
| 149,646 | 145,610 | |||||||
|
Less accumulated depreciation
|
(114,927 | ) | (68,898 | ) | ||||
|
NET PROPERTY & EQUIPMENT
|
34,719 | 76,712 | ||||||
|
OTHER ASSETS
|
||||||||
|
Patents
|
84,833 | 45,636 | ||||||
|
Trademark
|
4,467 | 4,467 | ||||||
|
Security deposit
|
9,650 | 9,650 | ||||||
|
TOTAL OTHER ASSETS
|
98,950 | 59,753 | ||||||
|
TOTAL ASSETS
|
$ | 473,107 | $ | 525,511 | ||||
|
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Accounts payable
|
$ | 56,288 | $ | 1,391 | ||||
|
Accrued expenses
|
46,942 | 52,985 | ||||||
|
Credit card payable
|
- | 470 | ||||||
|
Other payables
|
8,461 | 872 | ||||||
|
TOTAL LIABILITIES
|
111,691 | 55,718 | ||||||
|
SHAREHOLDERS' EQUITY
|
||||||||
|
Preferred stock, $0.0001 par value; 50,000 authorized preferred shares
|
- | - | ||||||
|
Common stock, $0.0001 par value; 500,000,000 authorized common shares 184,609,682 and 159,321,232 shares issued and outstanding
|
18,462 | 15,933 | ||||||
|
Additional paid in capital
|
11,506,494 | 7,160,260 | ||||||
|
Common stock subscription payable
|
184,500 | 161,040 | ||||||
|
Accumulated deficit
|
(11,348,040 | ) | (6,867,440 | ) | ||||
|
TOTAL SHAREHOLDERS' EQUITY
|
361,416 | 469,793 | ||||||
|
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$ | 473,107 | $ | 525,511 | ||||
|
Years Ended
|
||||||||
|
December 31,
2010
|
December 31,
2009
|
|||||||
|
REVENUE
|
$ | 45,500 | $ | - | ||||
|
General & administrative expenses
|
3,814,538 | 4,068,942 | ||||||
|
Research & development
|
662,347 | 790,399 | ||||||
|
Depreciation & amortization expense
|
46,029 | 55,772 | ||||||
|
TOTAL OPERATING EXPENSES
|
4,522,914 | 4,915,113 | ||||||
|
LOSS FROM OPERATIONS BEFORE OTHER INCOME/(EXPENSE)
|
(4,477,414 | ) | (4,915,113 | ) | ||||
|
OTHER INCOME/(EXPENSE)
|
||||||||
|
Interest income
|
6 | 29 | ||||||
|
Dividend income
|
32 | 899 | ||||||
|
Penalties
|
(2,424 | ) | (86 | ) | ||||
|
TOTAL OTHER INCOME/(EXPENSES)
|
(2,386 | ) | 842 | |||||
|
LOSS BEFORE PROVISION FOR TAXES
|
(4,479,800 | ) | (4,914,271 | ) | ||||
|
Income taxes
|
(800 | ) | (800 | ) | ||||
|
NET LOSS
|
$ | (4,480,600 | ) | $ | (4,915,071 | ) | ||
|
BASIC LOSS PER SHARE
|
$ | (0.03 | ) | $ | (0.03 | ) | ||
|
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED
|
167,136,623 | 150,941,578 | ||||||
|
Additional
|
Common
|
|||||||||||||||||||||||
|
Common stock
|
Paid-in
|
Stock
|
Accumulated
|
|||||||||||||||||||||
|
Shares
|
Amount
|
Capital
|
Payable
|
Deficit
|
Total
|
|||||||||||||||||||
|
Balance at December 31, 2008
|
144,180,050 | $ | 14,418 | $ | 1,827,980 | $ | 804,200 | $ | (1,952,369 | ) | $ | 694,229 | ||||||||||||
|
Common stock issued for cash and subscription payable
|
15,141,182 | 1,515 | 3,123,988 | (643,160 | ) | - | 2,482,343 | |||||||||||||||||
|
Options and warrant compensation expense
|
- | - | 2,211,306 | - | - | 2,211,306 | ||||||||||||||||||
|
Stock issuance cost
|
- | - | (3,014 | ) | - | - | (3,014 | ) | ||||||||||||||||
|
Net Loss for the year ended December 31, 2009
|
- | - | - | - | (4,915,071 | ) | (4,915,071 | ) | ||||||||||||||||
|
Balance at December 31, 2009
|
159,321,232 | 15,933 | 7,160,260 | 161,040 | (6,867,440 | ) | 469,793 | |||||||||||||||||
|
Common stock issued for cash and subscription payable
|
23,169,359 | 2,317 | 2,630,533 | 25,860 | - | 2,658,710 | ||||||||||||||||||
|
Common stock issued for services
|
929,091 | 93 | 221,307 | - | - | 221,400 | ||||||||||||||||||
|
Common stock issued for prepaids
|
1,000,000 | 100 | 219,900 | - | - | 220,000 | ||||||||||||||||||
|
Exercise of Class A warrants
|
190,000 | 19 | 22,781 | (2,400 | ) | - | 20,400 | |||||||||||||||||
|
Options and warrant compensation expense
|
- | - | 1,276,915 | - | - | 1,276,915 | ||||||||||||||||||
|
Stock issuance cost
|
- | - | (25,202 | ) | - | - | (25,202 | ) | ||||||||||||||||
|
Net loss for the year ended December 31, 2010
|
- | - | - | - | (4,480,600 | ) | (4,480,600 | ) | ||||||||||||||||
|
Balance at December 31, 2010
|
184,609,682 | $ | 18,462 | $ | 11,506,494 | $ | 184,500 | $ | (11,348,040 | ) | $ | 361,416 | ||||||||||||
|
Year Ended
|
||||||||
|
December 31,
2010
|
December 31,
2009
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net loss
|
$ | (4,480,600 | ) | $ | (4,915,071 | ) | ||
|
Adjustment to reconcile net loss to net cash used in operating activities
|
||||||||
|
Depreciation & amortization
|
46,029 | 55,772 | ||||||
|
Common stock issued for services
|
221,400 | - | ||||||
|
Stock compensation expense
|
1,276,915 | 2,211,306 | ||||||
|
Changes in Assets and Liabilities
|
||||||||
|
(Increase) Decrease in:
|
||||||||
|
Prepaid expenses
|
165,871 | (15,938 | ) | |||||
|
Other receivables
|
(14,018 | ) | - | |||||
|
Increase (Decrease) in:
|
||||||||
|
Accounts payable
|
54,897 | (16,480 | ) | |||||
|
Accrued expenses
|
(6,043 | ) | 31,102 | |||||
|
Credit card payable
|
(470 | ) | (1,837 | ) | ||||
|
Other payable
|
7,589 | (27,548 | ) | |||||
|
NET CASH USED IN OPERATING ACTIVITIES
|
(2,728,430 | ) | (2,678,694 | ) | ||||
|
CASH FLOWS USED FROM INVESTING ACTIVITIES:
|
||||||||
|
Patent and trademark expenditures
|
(39,197 | ) | (19,807 | ) | ||||
|
Purchase of fixed assets
|
(4,036 | ) | (4,704 | ) | ||||
|
NET CASH USED IN INVESTING ACTIVITIES
|
(43,233 | ) | (24,511 | ) | ||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Proceeds from common stock subscription payable
|
184,500 | 161,040 | ||||||
|
Proceeds from exercise of warrants
|
20,400 | - | ||||||
|
Proceeds for issuance of common stock, net of stock issuance cost
|
2,449,008 | 2,318,289 | ||||||
|
NET CASH PROVIDED BY FINANCING ACTIVITIES
|
2,653,908 | 2,479,329 | ||||||
|
NET DECREASE IN CASH
|
(117,755 | ) | (223,876 | ) | ||||
|
CASH & CASH EQUIVALENTS, BEGINNING OF YEAR
|
356,179 | 580,055 | ||||||
|
CASH & CASH EQUIVALENTS, END OF YEAR
|
$ | 238,424 | $ | 356,179 | ||||
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
|
||||||||
|
Interest paid
|
$ | - | $ | - | ||||
|
Taxes paid
|
$ | 800 | $ | 800 | ||||
|
Leasehold improvements
|
2 years
|
|
|
Computer equipment
|
5 Years
|
|
|
Furniture & fixtures
|
7 Years
|
|
|
Machinery & equipment
|
10 Years
|
|
2010
|
2009
|
||
|
Risk free interest rate
|
1.17%-2.04%
|
2.29%
|
|
|
Stock volatility factor
|
1%
|
1%
|
|
|
Weighted average expected option life
|
5 years
|
5 years
|
|
|
Expected dividend yield
|
None
|
None
|
|
2010
|
2009
|
|||||||||||||||
|
Weighted
|
Weighted
|
|||||||||||||||
|
Number
|
average
|
Number
|
average
|
|||||||||||||
|
of
|
exercise
|
of
|
exercise
|
|||||||||||||
|
Options
|
price
|
Options
|
price
|
|||||||||||||
|
Outstanding, beginning of period
|
4,150,000 | $ | 0.31 | - | $ | - | ||||||||||
|
Granted
|
11,665,000 | 0.21 | 4,150,000 | 0.31 | ||||||||||||
|
Exercised
|
- | - | - | - | ||||||||||||
|
Forfeited/Expired
|
(866,250 | ) | (0.31 | ) | - | - | ||||||||||
|
Outstanding, end of period
|
14,948,750 | $ | 0.24 | 4,150,000 | $ | 0.31 | ||||||||||
|
Exercisable at the end of period
|
1,785,993 | $ | 0.12 | 326,875 | $ | 0.31 | ||||||||||
|
Weighted average fair value of options granted during the period
|
$ | 0.21 | $ | 0.31 | ||||||||||||
|
Average
|
|||||||||||||||
|
Stock
|
Stock
|
Remaining
|
|||||||||||||
|
Exercisable
|
Options
|
Options
|
Contractual
|
||||||||||||
|
Prices
|
Outstanding
|
Exercisable
|
Life (years)
|
||||||||||||
| $ | 0.32 | 187,500 | 62,158 | 2.50 | |||||||||||
| $ | 0.23 | 6,250 | 963 | 2.50 | |||||||||||
| $ | 0.32 | 2,640,000 | 875,178 | 3.68 | |||||||||||
| $ | 0.28 | 100,000 | 30,753 | 3.77 | |||||||||||
| $ | 0.30 | 450,000 | 136,233 | 3.79 | |||||||||||
| $ | 0.23 | 2,700,000 | 416,095 | 4.39 | |||||||||||
| $ | 0.24 | 3,050,000 | 208,904 | 4.73 | |||||||||||
| $ | 0.15 | 1,000,000 | 26,027 | 4.90 | |||||||||||
| $ | 0.20 | 4,815,000 | 29,682 | 4.98 | |||||||||||
| 14,948,750 | 1,785,993 | ||||||||||||||
|
2010
|
2009
|
||
|
Risk free interest rate
|
1.51% - 2.5%
|
2.41% - 2.5%
|
|
|
Stock volatility factor
|
1%
|
1%
|
|
|
Weighted average expected option life
|
5 years
|
5 years
|
|
|
Expected dividend yield
|
None
|
None
|
|
Year End
|
Year End
|
|||||||||||||||
|
December 31, 2010
|
December 31, 2009
|
|||||||||||||||
|
Weighted
|
Weighted
|
|||||||||||||||
|
average
|
average
|
|||||||||||||||
|
exercise
|
exercise
|
|||||||||||||||
|
Warrants
|
price
|
Warrants
|
price
|
|||||||||||||
|
Outstanding -beginning of year
|
12,000,000 | $ | 0.31 | - | $ | - | ||||||||||
|
Granted
|
10,640,000 | 0.11 | 12,000,000 | 0.31 | ||||||||||||
|
Exercised
|
- | - | - | - | ||||||||||||
|
Forfeited
|
(625,000 | ) | (0.31 | ) | - | - | ||||||||||
|
Outstanding - end of year
|
22,015,000 | $ | 0.14 | 12,000,000 | $ | 0.31 | ||||||||||
|
Weighted
|
|||||||||||||||
|
Average
|
|||||||||||||||
|
Remaining
|
|||||||||||||||
|
Exercisable
|
Warrants
|
Warrants
|
Contractual
|
||||||||||||
|
Prices
|
Outstanding
|
Exercisable
|
Life (years)
|
||||||||||||
| $ | 0.31 | 9,700,000 | 9,700,000 | 3.50 | |||||||||||
| $ | 0.34 | 1,100,000 | 900,000 | 3.63 | |||||||||||
| $ | 0.30 | 525,000 | 525,000 | 3.81 | |||||||||||
| $ | 0.28 | 250,000 | 250,000 | 3.87 | |||||||||||
| $ | 0.28 | 20,000 | 20,000 | 4.08 | |||||||||||
| $ | 0.28 | 150,000 | 150,000 | 4.41 | |||||||||||
| $ | 0.24 | 1,000,000 | 1,000,000 | 4.48 | |||||||||||
| $ | 0.31 | 220,000 | 220,000 | 4.59 | |||||||||||
| $ | 0.15 | 350,000 | 350,000 | 4.70 | |||||||||||
| $ | 0.24 | 250,000 | 250,000 | 4.73 | |||||||||||
| $ | 0.24 | 1,000,000 | 1,000,000 | 4.75 | |||||||||||
| $ | 0.12 | 250,000 | 250,000 | 4.83 | |||||||||||
| $ | 0.15 | 1,000,000 | 1,000,000 | 4.90 | |||||||||||
| $ | 0.14 | 400,000 | 400,000 | 4.92 | |||||||||||
| $ | 0.20 | 5,000,000 | 5,000,000 | 4.98 | |||||||||||
| $ | 0.20 | 1,000,000 | 1,000,000 | 4.99 | |||||||||||
| 22,215,000 | 22,015,000 | ||||||||||||||
|
2010
|
2009
|
|||||||
|
Patents
|
$ | 84,833 | $ | 45,636 | ||||
|
Trademarks
|
4,467 | 4,467 | ||||||
| $ | 89,300 | $ | 50,103 | |||||
|
6.
|
INCOME TAXES
|
|
|
The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2008.
|
|
|
Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amounts when the realization is uncertain. Included in the balance at December 31, 2010 and 2009, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period.
|
|
|
The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2010 and 2009, the Company did not recognize interest and penalties.
|
|
7.
|
DEFERRED TAX BENEFIT
|
|
|
At December 31, 2010, the Company had net operating loss carry-forwards of approximately $7,655,000, which expire at dates that have not been determined. No tax benefit has been reported in the December 31, 2010 financial statements since the potential tax benefit is offset by a valuation allowance of the same amount.
|
|
|
The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2010 and 2009 due to the following:
|
|
2010
|
2009
|
|||||||
|
Book income
|
$ | (1,792,560 | ) | $ | (1,966,029 | ) | ||
|
State tax expense
|
(320 | ) | (320 | ) | ||||
|
Depreciation
|
9,449 | 7,044 | ||||||
|
M & E
|
3,303 | 3,966 | ||||||
|
Related party accruals
|
16,664 | - | ||||||
|
R&D
|
23,951 | (12,884 | ) | |||||
|
Non deductible stock compensation
|
511,736 | 884,557 | ||||||
|
Valuation Allowance
|
1,227,777 | 1,083,346 | ||||||
|
Income tax expense
|
$ | 800 | $ | 800 | ||||
|
7.
|
DEFERRED TAX BENEFIT (continued)
|
|
|
Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.
|
|
|
Net deferred tax liabilities consist of the following components as of December 31, 2010 and 2009.
|
|
2010
|
2009
|
|||||||
|
Deferred tax assets:
|
||||||||
|
NOL carryover
|
$ | 3,061,906 | $ | 1,876,125 | ||||
|
R & D carryover
|
60,435 | 20,788 | ||||||
|
Contributions carryover
|
332 | - | ||||||
|
Accrued vacation payable
|
16,664 | - | ||||||
|
Deferred tax liabilities:
|
||||||||
|
Depreciation
|
(7,378 | ) | (16,827 | ) | ||||
|
Less Valuation Allowance
|
(3,131,959 | ) | (1,880,086 | ) | ||||
|
Net deferred tax asset
|
$ | - | $ | - | ||||
|
|
Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years.
|
|
8.
|
SUBSEQUENT EVENTS
|
|
|
Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|